Taken together, NEP inhibitors have beneficial effects on glucose homeostasis and insulin sensitivity by increasing various substrates including GLP‐1 and thus, could be effective alone or in combination with antidiabetic agents in treating T2DM patients. The gene discussed is GCG; the disease is type 2 diabetes mellitus.